Serum FGF21 as a Biomarker in Prediabetes and Type 2 Diabetes: Diagnostic,  Prognostic, and Therapeutic Implications

Nermin Saad Ghanem , Aya Mustafa Omar Alfoghi , Mohamed Abu Taleb, Houda Gouda

Serum FGF21 as a Biomarker in Prediabetes and Type 2 Diabetes: Diagnostic, Prognostic, and Therapeutic Implications

Authors

Nermin Saad Ghanem , Aya Mustafa Omar Alfoghi , Mohamed Abu Taleb, Houda Gouda

Keywords:

Serum FGF21, Prediabetes, Type 2 Diabetes

Abstract

Background: Background: The endocrine fibroblast growth factor hormone Fibroblast Growth Factor 21 (FGF21)has emerged as a key metabolic regulator responsive to nutrient stress, hepatic lipotoxicity and insulin‐resistance states. Its circulating concentration

References

Fisher FM, Kleiner S, Douris N, et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Cell Metab. 2010;12(1):32–42

Downloads

Published

2024-05-20

How to Cite

Nermin Saad Ghanem , Aya Mustafa Omar Alfoghi , Mohamed Abu Taleb, Houda Gouda. (2024). Serum FGF21 as a Biomarker in Prediabetes and Type 2 Diabetes: Diagnostic, Prognostic, and Therapeutic Implications. Journal of Computational Analysis and Applications (JoCAAA), 33(06), 3642–3653. Retrieved from https://eudoxuspress.com/index.php/pub/article/view/4091